TransCode Therapeutics, Inc.
USD6.21
+0.97 (+18.51%)
CEO
Philippe Calais
IPO Date
2021-07-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.15
Prev. Close
$5.24
Day Low
$4.97
Day High
$6.30
52W Low
$3.82
52W High
$20.99
Market Cap
$0.01B
Volume
0.05M
| -1.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -1130.3% | -358.7% | 0.27 | 1.28 | -1.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -542.0% | -231.5% | 0.00 | 1.70 | -321.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -33.5% | -29.8% | 0.00 | 8.97 | -2022.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 68.8% | -222.1% | -0.61 | 2.05 | -9318.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 55.3% | -280.2% | -0.85 | 3.25 | -28882.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 90.0% | -211.3% | -0.94 | 1.82 | -1160.3 |
| -0.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -340.5% | -92.9% | 0.00 | 1.60 | -0.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -69.6% | -51.7% | 0.00 | 5.27 | -0.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -117.4% | -91.6% | 0.00 | 5.20 | -0.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 293.1% | -81.1% | -0.02 | 2.56 | -1.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -140.5% | -59.0% | 0.09 | 1.58 | -14.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -392.6% | -107.6% | 0.17 | 1.25 | -6.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -72.6% | -45.6% | 0.07 | 2.48 | -5.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -249.1% | -79.1% | 0.27 | 1.28 | -1.4 |